81 related articles for article (PubMed ID: 3083030)
1. Impaired cell-mediated immunity in hemophilia: suppression of natural killer activity by factor VIII.
Ablin RJ; Bartkus JM
J Lab Clin Med; 1986 Apr; 107(4):396-7. PubMed ID: 3083030
[No Abstract] [Full Text] [Related]
2. Impaired cell-mediated immunity in patients with classic hemophilia.
Lederman MM; Ratnoff OD; Scillian JJ; Jones PK; Schacter B
N Engl J Med; 1983 Jan; 308(2):79-83. PubMed ID: 6216408
[No Abstract] [Full Text] [Related]
3. [Combined plasmapheresis and immunosuppression in hemophilia in a patient with antibodies].
Révész T; Mátyus J; Goldschmidt B; Harsányi V
Orv Hetil; 1980 Jul; 121(29):1753-4. PubMed ID: 6779250
[No Abstract] [Full Text] [Related]
4. Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII).
Ratnoff OD; Menitove JE; Aster RH; Lederman MM
N Engl J Med; 1983 Feb; 308(8):439-42. PubMed ID: 6401839
[No Abstract] [Full Text] [Related]
5. The natural history of factor VIII inhibitors in patients with hemophilia A.
Gill FM
Prog Clin Biol Res; 1984; 150():19-29. PubMed ID: 6431427
[No Abstract] [Full Text] [Related]
6. CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjects.
Reding MT; Wu H; Krampf M; Okita DK; Diethelm-Okita BM; Key NS; Conti-Fine BM
Thromb Haemost; 1999 Aug; 82(2):509-15. PubMed ID: 10605744
[TBL] [Abstract][Full Text] [Related]
7. HLA antigens and factor VIII antibody in classic hemophilia. European study group of factor VIII antibody.
Frommel D; Allain JP; Saint-Paul E; Bosser C; Noël B; Mannucci PM; Pannicucci F; Blombäck M; Prou-Wartelle O; Muller JY
Thromb Haemost; 1981 Dec; 46(4):687-9. PubMed ID: 6800049
[TBL] [Abstract][Full Text] [Related]
8. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
White GC; Greenwood R; Escobar M; Frelinger JA
Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
[TBL] [Abstract][Full Text] [Related]
9. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
10. Desensitization to factor VIII in a patient with classic hemophilia and C2 deficiency.
Jamieson DM; Stafford CT; Maloney MJ; Lutcher CL
Ann Allergy; 1987 Mar; 58(3):215-20. PubMed ID: 3103496
[TBL] [Abstract][Full Text] [Related]
11. Idiotypic regulation of anti-factor VIII antibodies.
Kazatchkine MD; Lacroix-Desmazes S; Moreau A; Kaveri SV
Haematologica; 2000 Oct; 85(10 Suppl):97-9. PubMed ID: 11187885
[TBL] [Abstract][Full Text] [Related]
12. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
13. [Incidence of the appearance of factor VIII inhibitor in patients with hemophilia A at the Hemophilia Center of the Clinical Hospital Center in Zagreb].
Ficović P; Tiefenbach A; Brkljacić V; Grgić Z
Lijec Vjesn; 1983 Oct; 105(10):410-1. PubMed ID: 6418997
[No Abstract] [Full Text] [Related]
14. T lymphocyte proliferative responses induced by recombinant factor VIII in hemophilia A patients with inhibitors.
Singer ST; Addiego JE; Reason DC; Lucas AH
Thromb Haemost; 1996 Jul; 76(1):17-22. PubMed ID: 8819245
[TBL] [Abstract][Full Text] [Related]
15. Postpartum acquired factor VIII inhibitors.
Franchini M
Am J Hematol; 2006 Oct; 81(10):768-73. PubMed ID: 16868941
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of anti-human and anti-porcine factor VIII antibody titers in patients with hemophilia].
Windyga J; Rzymkiewicz L; Lopaciuk S
Acta Haematol Pol; 1996; 27(1):27-31. PubMed ID: 8629440
[TBL] [Abstract][Full Text] [Related]
17. [Cellular immunology status in 5 hemophilic patients with inhibitors subjected to massive therapy with factor VIII concentrate].
Aznar JA; Jorquera JI; González Molina A; Carbonell F; Trenor A; Sánchez Cuenca JM; de Andrés R
Sangre (Barc); 1983; 28(5):663-4. PubMed ID: 6420915
[No Abstract] [Full Text] [Related]
18. HLA-DR and Factor VIII antibodies in hemophilia A.
Mayr WR; Lechner K; Niessner H; Pabinger-Fasching I
Thromb Haemost; 1984 Apr; 51(2):293. PubMed ID: 6429887
[No Abstract] [Full Text] [Related]
19. [Occurrence of anti-factor VIII antibodies in children with hemophilia].
Klukowska A; Adamowicz-Salach A; Kamińska D
Acta Haematol Pol; 1987; 18(1-2):123-6. PubMed ID: 3124483
[No Abstract] [Full Text] [Related]
20. Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients.
Hoyer LW; Scandella D
Semin Hematol; 1994 Apr; 31(2 Suppl 4):1-5. PubMed ID: 7524160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
